These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35995729)

  • 1. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up.
    Fairbrass KM; Hamlin PJ; Gracie DJ; Ford AC
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1264-1273. PubMed ID: 35995729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Gracie DJ; Hamlin JP; Ford AC
    Am J Gastroenterol; 2018 May; 113(5):702-712. PubMed ID: 29453384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.
    Goodoory VC; Guthrie EA; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 Feb; 57(3):323-334. PubMed ID: 36544055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
    Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
    Ozer M; Bengi G; Colak R; Cengiz O; Akpinar H
    Medicine (Baltimore); 2020 May; 99(19):e20067. PubMed ID: 32384473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and sleep in individuals with irritable bowel syndrome according to different diagnostic criteria and inflammatory bowel diseases: A comparison using data from a population-based survey.
    Schwille-Kiuntke J; Ittermann T; Schmidt CO; Grabe HJ; Lerch MM; Völzke H; Rieger MA; Enck P; Schauer B
    Z Gastroenterol; 2022 Mar; 60(3):299-309. PubMed ID: 35263783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW; Green JT; Hood K; Campbell AK
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
    Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.
    Lee AD; Spiegel BM; Hays RD; Melmed GY; Bolus R; Khanna D; Khanna PP; Chang L
    Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27981684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
    Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.